- Home
- BDTX vs CPBI Comparison
BDTX vs CPBI Comparison
Compare BDTX & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | CPBI |
|---|---|---|
| Founded | 2014 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 83.2M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BDTX | CPBI |
|---|---|---|
| Price | $1.84 | $20.75 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 857.5K | 3.5K |
| Earning Date | 11-09-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | 9.38 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $52.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $15.56 |
| 52 Week High | $4.94 | $21.83 |
Technical Indicators
Market Signals| Indicator | BDTX | CPBI |
|---|---|---|
| Relative Strength Index (RSI) | 48.17 | 56.52 |
| Support Level | $1.83 | $19.74 |
| Resistance Level | $1.93 | $21.67 |
| Average True Range (ATR) | 0.15 | 0.29 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 43.52 | 87.18 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans. The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans. The company's revenue is derived from the business of banking.